Skip to main content

Table 2 Fasting lipids, lipoproteins and apolipoproteins in the three periods of treatment

From: Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report

  (A) Diet (B) Diet plus Fluvastatin 80 mg (C) Diet plus Fluvastatin 80 mg plus Omacor 4 g
Total Cholesterolac 259 ± 55 174 ± 35 203 ± 54
LDL cholesterolac 157 ± 47 103 ± 25 127 ± 30
HDL cholesterolbc 34 ± 9 32 ± 10 40 ± 11
Non-HDL cholac 225 ± 55 142 ± 35 163 ± 54
Triglyceridesc 337 ± 153 263 ± 226 195 ± 129
VLDL triglyceridesc 289 ± 160 224 ± 222 136 ± 118
Tg/HDL-chol ratioc 4.80 ± 2.69 4.39 ± 5.10 2.23 ± 1.56
Apo A-1 113 ± 24 107 ± 41 124 ± 26
Apo B100ac 126 ± 34 89 ± 16 82 ± 16
Apo B48c 5.81 ± 2.59 4.12 ± 2.78 3.07 ± 1.47
Apo C-IIac 20.4 ± 6.1 18.1 ± 5.6 15.8 ± 6.8
Apo C-III a 18.7 ± 5.7 12.9 ± 3.5 12.8 ± 4.7
C-II/C-III ratio 1.13 ± 0.31 1.41 ± 0.29 1.30 ± 0.16
  1. Data showed as mg/dL except apo B48, in mg/L.
  2. a (A) vs (B) p < 0.05.
  3. b (B) vs (C) p < 0.05.
  4. c (A) vs (C) p < 0.05.